A Multicentre Randomised, Double blind, placebo controlled trial to Evaluate the effect of Dapagliflozin 10mg Once daily on the incidence of cardiovascular death, Myocardial infarction or the Ischemic

Project: Research

StatusFinished
Effective start/end date1/08/1329/04/16